| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.0074 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.004 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |